Pictet Asset Management (Switzerland)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $127M | Buy |
3,095,670
+1,982,628
| +178% | +$81.3M | 0.15% | 174 |
|
|
2023
Q1 | $39.8M | Buy |
1,113,042
+739,456
| +198% | +$26.4M | 0.05% | 328 |
|
|
2022
Q4 | $14.1M | Buy |
373,586
+96,609
| +35% | +$3.65M | 0.02% | 519 |
|
|
2022
Q3 | $12.3M | Buy |
276,977
+38,638
| +16% | +$1.71M | 0.02% | 532 |
|
|
2022
Q2 | $8.82M | Buy |
238,339
+32,198
| +16% | +$1.19M | 0.01% | 627 |
|
|
2022
Q1 | $7.64M | Buy |
206,141
+23,054
| +13% | +$854K | 0.01% | 707 |
|
|
2021
Q4 | $5.57M | Buy |
183,087
+47,391
| +35% | +$1.44M | 0.01% | 803 |
|
|
2021
Q3 | $4.55M | Buy |
+135,696
| New | +$4.55M | 0.01% | 851 |
|